The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
Heart Health AI firm, Tricog has raised 8.5 million USD in a Series B2 funding round from Omron Healthcare, Japan and Sony Innovation Fund, Japan. Existing investors UTEC – The University of Tokyo Edge Capital, Japan, Inventus Partners LLP and SG Innovate, Singapore, participated in this round.
The round marks a total raise of USD 30M. Tricog’s AI platform aims to make cardiac diagnosis and management accessible and affordable by deepening the partnerships with government and large private healthcare networks and building state-of-the-art technology for next-generation products, enabling wider reach in patient populations and disease conditions.
Tricog’s platform has been deployed in over 5000 Cath Labs, Hospitals, Clinics and Diagnostic Centres to help diagnose and manage patients with critical cardiac diseases, including heart attacks. The platform is deployed across five state governments and numerous private healthcare networks, significantly reducing mortality and morbidity.
Dr Charit Bhograj, Founder & CEO, Tricog Health said, “The last five years have witnessed tremendous advancements in our AI and technology platform that have allowed us to serve millions of patients across multiple continents. With this round, we are committed to expanding our reach to Asia and Africa and our footprint in the US healthcare market. In addition, our strategic partnerships will allow us, for the first time, to address the needs of heart patients at home, the direction where healthcare will be.”
Tricog has recently developed the TriCare platform, an integrated solution for chronic disease management. The first focus will address the global healthcare challenge of heart failure within the US healthcare system and Asia. The TriCare platform enables remote management of heart disease using medical data from connected devices at home and wearable devices such as the Apple Watch. The TriCare platform addresses a growing $110B market segment opportunity.
- Advertisement -